Insider Trading Alert - APA, ARW And MJN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 29, 2014, 124 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $783.36 to $53,794,125.00.

Highlighted Stocks Traded by Insiders:

Apache Corporation (APA) - FREE Research Report

Jeppesen Jon A, who is Retired Officer at Apache Corporation, sold 10,145 shares at $92.04 on May 29, 2014. Following this transaction, the Retired Officer owned 59,640 shares meaning that the stake was reduced by 14.54% with the 10,145-share transaction.

The shares most recently traded at $93.30, up $1.26, or 1.35% since the insider transaction. Historical insider transactions for Apache Corporation go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 7,622
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 14,022
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 18,783

The average volume for Apache Corporation has been 3.1 million shares per day over the past 30 days. Apache Corporation has a market cap of $35.4 billion and is part of the basic materials sector and energy industry. Shares are up 8.28% year-to-date as of the close of trading on Thursday.

Apache Corporation, an independent energy company, explores for, develops, and produces natural gas, crude oil, and natural gas liquids. The stock currently has a dividend yield of 1.09%. The company has a P/E ratio of 16.7. Currently, there are 10 analysts who rate Apache Corporation a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on APA - FREE

TheStreet Quant Ratings rates Apache Corporation as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Apache Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Arrow Electronics (ARW) - FREE Research Report

Kerins Sean J, who is President, Global ECS at Arrow Electronics, sold 5,000 shares at $56.62 on May 29, 2014. Following this transaction, the President, Global ECS owned 6,117 shares meaning that the stake was reduced by 44.98% with the 5,000-share transaction.

The shares most recently traded at $57.57, up $0.95, or 1.65% since the insider transaction. Historical insider transactions for Arrow Electronics go as follows:

  • 4-Week # shares sold: 4,300
  • 12-Week # shares sold: 4,300
  • 24-Week # shares sold: 108,002

The average volume for Arrow Electronics has been 589,300 shares per day over the past 30 days. Arrow Electronics has a market cap of $5.8 billion and is part of the services sector and wholesale industry. Shares are up 6.82% year-to-date as of the close of trading on Thursday.

Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions worldwide. It operates in two segments, Global Components and Global Enterprise Computing Solutions. The company has a P/E ratio of 13.8. Currently, there are 4 analysts who rate Arrow Electronics a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARW - FREE

TheStreet Quant Ratings rates Arrow Electronics as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Arrow Electronics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mead Johnson Nutrition (MJN) - FREE Research Report

Singer Robert S, who is Director at Mead Johnson Nutrition, sold 3,000 shares at $87.40 on May 29, 2014. Following this transaction, the Director owned 18,676 shares meaning that the stake was reduced by 13.84% with the 3,000-share transaction.

Hondmann Dirk, who is SVP, Global R&D at Mead Johnson Nutrition, sold 14,559 shares at $87.83 on May 29, 2014. Following this transaction, the SVP, Global R&D owned 0 shares meaning that the stake was reduced by 100% with the 14,559-share transaction.

The shares most recently traded at $88.85, up $1.02, or 1.15% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 11,503
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 31,503
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 92,207

The average volume for Mead Johnson Nutrition has been 1.4 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $17.6 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 5.18% year-to-date as of the close of trading on Thursday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.72%. The company has a P/E ratio of 26.6. Currently, there are 6 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Mead Johnson Nutrition Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%